CYD
China Yuchai International Limited
28.20$
-12.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.4% | -3.3% | +3.4% | – | – | +0.0% | +0.0% | -6.6% | +26.5% | +0.0% | -12.6% | |
| – | +288.6% | -68.6% | +0.0% | -51.8% | +607.6% | +0.0% | +0.0% | +23.1% | -0.4% | +0.0% | +11.0% | |
| – | +617.1% | -208.4% | – | – | +577.7% | +6.7% | +0.0% | +24.1% | +0.2% | +0.0% | +3.2% | |
| – | +677.5% | +0.0% | +0.0% | -85.5% | +623.2% | +1.9% | -1.9% | +24.1% | – | – | +3.2% | |
| – | +531.2% | -81.0% | +426.1% | +29.3% | -12.6% | -82.0% | +479.3% | +37.6% | -80.7% | +365.1% | +22.9% | |
| – | -5.7% | +0.4% | -0.4% | -1.9% | +2.0% | +0.4% | +0.0% | +0.4% | +19.0% | +0.0% | +3.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | – | – | +0.0% | +0.0% | – | – | +0.0% | – | |
| – | – | +38.6% | -27.8% | – | – | +46.1% | +0.0% | – | – | +0.0% | – | |
| – | +69.7% | -189.6% | – | – | +845.3% | +0.0% | +0.0% | -4.4% | +35.3% | +0.0% | -23.2% | |
| – | +50.7% | +0.0% | +0.0% | -90.2% | +1,024.0% | +0.0% | +0.0% | -9.9% | +51.7% | +0.0% | -26.9% | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | -45.2% | +0.0% | +0.0% | +95.0% | -44.2% | +0.0% | +0.0% | +149.8% | -40.1% | +0.0% | +85.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +32.0% | +0.0% | -22.2% | -3.3% | +0.0% | +0.0% | +2.6% | +1.9% | +0.0% | +6.1% | |
| – | – | -5.3% | +5.6% | – | – | -6.0% | +0.0% | – | – | +0.0% | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -7.5% | +0.0% | 0.0% | -0.7% | +0.0% | +0.0% | +0.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.